A high-performance liquid chromatography-photodiode array detector method was established for the simultaneous determination of 7 components in Cheonwangbosimdan extract. The components were 5-hydroxymethyl-2-furaldehyde (1), coptisine (2), berberine (3), nodakenin (4), harpagoside (5), cinnamic acid (6), and β-asarone (7). All analytes were separated by gradient elution using two mobile phases on a Gemini C 18 column and maintained at 40°C. The flow rate was 1.0 mL/min and the injection volume was 10 L. Calibration curves of the 7 compounds showed good linearity with correlation coefficients (r 2 ) ≥ 0.9996. The limits of detection and quantification of the 7 analytes were 0.01-0.04 and 0.03-0.12 g/mL, respectively. The recoveries of the 7 marker constituents were 97.6-104.2% with relative standard deviations (RSD) of less than 2.2%. The RSD values of intra-and interday precision were 0.11-1.78 and 0.19-1.92%, respectively. Among the 7 biomarker compounds, the major compounds of Cheonwangbosimdan were berberine and coptisine, which originated from Coptis japonica. The results indicate that the developed analytical method is suitable for quality control use.
Several analytical methods have been reported for the analysis of particular components in CBD, including catalpol and salvianolic acid B using high-performance liquid chromatography (HPLC) with UV detection [8, 9] , spinosin using both thin-layer chromatography and HPLC with photodiode array (PDA) detection [10] , and jujuboside A using HPLC with evaporative lightscattering detection [11] . However, these approaches have limited use as methods for simultaneous determination of components and they have not been validated as analytical methods for quality control of CBD extracts. In this study, we carried out simultaneous determination and method validations of 7 bioactive components including 5-hydroxymethyl-2-furaldehyde (5-HMF, 1), coptisine (2), berberine (3), nodakenin (4), harpagoside (5) , cinnamic acid (6) , and β-asarone (7) for quality control of CBD by using HPLC-PDA. The components investigated were: berberine and coptisine from C. japonica [12] , β-asarone from A. gramineus [13] , nodakenin from A. gigas [14] , 5-hydroxymethyl-2-furaldehyde (5-HMF) from A. cochinchinensis [15] , and cinnamic acid and harpagoside from S. buergeriana [16] .
HPLC conditions were varied with respect to the column used (Phenomenex Gemini C 18 , Waters SunFire C 18 , and OptimaPak C 18 column), the column temperature (30, 35, and 40°C), and the mobile phases (water-methanol, water-acetonitrile, acetic acid solution-methanol, acetic acid solution-acetonitrile, acetic acid solution-acetic acid in methanol, and acetic acid solution-acetic acid in acetonitrile) to establish the optimum separation of the 7 analytes. As a result, the Phenomenex Gemini C 18 column and 1.0% (v/v) acetic acid solution (pH 2.76)-1.0% (v/v) acetic acid in acetonitrile (pH 2.38) at a column temperature of 40°C were selected. The PDA wavelengths for simultaneous detection were set at 280 (5-HMF, harpagoside, and cinnamic acid), 300 (β-asarone), 335 (nodakenin), and 350 nm (coptisine and berberine). Under the optimized chromatography conditions, the 7 analytes were separated within 35 min with a resolution of more than 1.62 (Table 1 ). For calibration curves of all compounds, the tested concentration ranges were as follows: compounds 1, 5, and 6, 0.08-10.00 g/mL; compound 2, 0.39-50.00 g/mL; compounds 4 and 7, 0.31-40.00 g/mL; and compound 3, 1.56-200.00 g/mL. The linearity of each calibration curve was evaluated from the correlation coefficient (r 2 ) and all showed good linearity with r 2  0.9996 in the eight different concentration ranges ( Table 2 ). The limit of detection (LOD) and limit of quantification (LOQ) ranges of the 7 tested components were 0.01-0.04 and 0.03-0.12 g/mL, respectively; the results are summarized in Table 2 . The recovery test was performed on the compounds 1-7. The range of recoveries for the seven compounds was 97.6-101.6, 97.6-101.9, and 100.7-104.2% at the low, middle, and high concentrations, respectively and the relative standard deviation (RSD) values were in all cases less than 2.17% ( Table 3 ). As shown in Table 4 , the RSD values for repeatability of the method with the compounds 1-7 were 0.59-0.93% for peak responses and 0.02-0.17% for retention times. The precisions of intra-and inter-day variations for compounds 1-7 were evaluated by analyzing the CBD extract. The RSD of intra-and inter-day precision of the seven compounds were found to range from 0.11 to 1.78% and from 0.19 to 1.92%, respectively; the data are summarized in Table  5 . These results indicated that the developed HPLC-PDA method has good recovery, repeatability, and precision for the simultaneous analysis of all the analytes under consideration.
The validated HPLC-PDA method was applied to the simultaneous quantification of the 7 marker compounds in the CBD traditional herbal medicine. As shown in Table 6 , berberine and coptisine, which are marker components of C. japonica, were found to be the major constituents of the CBD samples; these compounds were found in amounts of 12.74 and 2.54 mg/g, respectively.
In conclusion, a convenient, accurate, and reliable HPLC-PDA method has been developed and validated for the first time for the (3), nodakenin (4), harpagoside (5), cinnamic acid (6), and β-asarone (7) . simultaneous separation and determination of 7 marker ingredients in the CBD traditional herbal formula. The validation process confirmed that the method showed good linearity, repeatability, intra and inter-day precision, and recovery. In addition, this analytical method was used successfully for the simultaneous analysis of compounds in the CBD extract for the purpose of quality control. The new HPLC-PDA analytical method could be used for quality assessment of CBD samples and other related traditional Korean medicines.
Experimental

Chemicals and materials:
Reference standards berberine and coptisine were purchased from Wako (Osaka, Japan), cinnamic acid and harpagoside from ChemFaces (Wuhan, China), and β-asarone, nodakenin, and 5-HMF from Carl Roth (Karlsruhe, Germany), NPC Bio Technology (Yeongi, Korea), and Sigma-Aldrich (St. Louis, MO, USA), respectively. The purities of the 7 reference standards were more than 98.0% according to HPLC analysis. HPLC-grade methanol,
Simultaneous quantification of marker constituents in Cheonwangbosimdan
Natural Product Communications Vol. 9 (12) 
Apparatus and conditions:
Chromatographic analysis for simultaneous determination of the analytes was conducted with a Prominence LC-20A series HPLC system (Shimadzu, Kyoto, Japan), which consisted of a solvent delivery unit (LC-20AT), online degasser (DGU-20A 3 ), column oven (CTO-20A), auto sample injector (SIL-20AC), and PDA detector (SPD-M20A). The acquired data were processed by LCsolution software (Version 1.24; Shimadzu) . The column used for separation of the 7 marker compounds was a Gemini C 18 column (250 mm  4.6 mm; 5 m particle size; Phenomenex, Torrance, CA, USA), maintained at 40°C. Gradient elution was performed with two mobile phase systems: (A) 1.0%, v/v, acetic acid in water, and (B) 1.0%, v/v, acetic acid in acetonitrile. The gradient profile was as follows: 5-60% B for 0-30 min, 60-100% B for 30-40 min, 100% B for 40-45 min, and 100-5% B for 45-50 min. Flow rate and injection volume were 1.0 mL/min and 10 L, respectively. The PDA detector was monitored at 280, 300, 335, and 350 nm according to the maximum absorption wavelengths of the reference standards.
Preparation of standard solutions:
Each of the 7 reference compounds was accurately weighed and dissolved in methanol at a concentration of 1.0 mg/mL. The stock solutions were stored at 4°C.
Preparation of sample solutions:
The 15 dried crude herbal medicines listed in Table 7 (5000 g; 48.75 g  102.6) were extracted in a tenfold mass of water at 100°C for 2 h under pressure (1 kgf/cm 2 ) using an electric extractor (COSMOS-660; Kyungseo Machine Co., Incheon, Korea). The water extract was then filtered through a standard sieve (no. 270, 53 m; Chung Gye Sang Gong Sa, Seoul, Korea) and the solution was freeze dried to give a powder. The yield of CBD extract was 21.3% (1065.1 g). For HPLC analysis, 100 mg of the lyophilized CBD extract was dissolved in 20 mL of 70% methanol. The solution was filtered through a 0.2 m syringe filter (Woongki Science, Seoul, Korea) before injection into the HPLC system. Method validations: All of the validation including linearity, intra-and inter-day precision, and accuracy of the developed analytical method were conducted according to the guidelines prescribed at the International Conference on Harmonization [17] . The calibration curves of 7 marker compounds were measured in triplicate and calculated by plotting the peak areas (y) versus the corresponding concentrations (x, g/mL) using standard solutions. The LOD and LOQ data were determined at signal-to-noise ratios of 3 and 10, respectively. Intra and inter-day variations, which were used to evaluate the precision of the new HPLC method, were determined by using the standard addition method for samples spiked with low, middle, and high concentrations of analyte. The RSD was used as a measure of precision; this value was calculated as follows: RSD (%) = (standard deviation (SD) / mean measured concentration)  100. To confirm the repeatability, 6 replicates using the mixed standard stock solutions were measured and compared. The RSD values of peak areas and retention times of each compound were used to evaluate the repeatability of the method. A recovery test was used to assess the accuracy of the developed method: this test was conducted by adding known amounts of low, middle, and high concentration levels of standard solutions to CBD extract (100 mg). Recovery was calculated as follows: Recovery (%) = (found concentrationoriginal concentration) / spiked concentration  100
